Drug
Bic Len Fdc
Bic Len Fdc: highest development phase Post-Market, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| BIC/LEN FDC NCT07908446 | Post-Market | HIV-1 Infection |
Latest
No recent events.
Follow Bic Len Fdc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.